Entrepreneurship in Biotechnology Managing for Growth from Start-Up to Initial Public Offering
Research and development of novel medicines for human therapy commonly takes over a decade before significant revenues from sales are forthcoming. How can biotechnology companies be founded and grow successfully in an industry with such extended innovation processes? The book investigates this probl...
| Main Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Heidelberg
Physica
2003, 2003
|
| Edition: | 1st ed. 2003 |
| Series: | Contributions to Management Science
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
| Summary: | Research and development of novel medicines for human therapy commonly takes over a decade before significant revenues from sales are forthcoming. How can biotechnology companies be founded and grow successfully in an industry with such extended innovation processes? The book investigates this problem and distinguishes three growth phases: From incorporation and start-up through collaborative R&D with large pharmaceutical firms to value creation from R&D pipelines to Public Offerings and product marketing. In this book a dynamic simulation model for testing different decision-making strategies is developed. For each phase the author identifies decision rules that provide for successful corporate growth |
|---|---|
| Physical Description: | XVI, 323 p online resource |
| ISBN: | 9783642574320 |